FARMACOLOGIA DE PRODUCTOS NATURALES
FARMACOLOGIA DE PRODUCTOS NATU
Instituto de Salud Carlos III
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Salud Carlos III (14)
2024
-
Differing contributions of the gut microbiota to the blood pressure lowering effects induced by first-line antihypertensive drugs
British Journal of Pharmacology, Vol. 181, Núm. 18, pp. 3420-3444
-
Versican accumulation drives Nos2 induction and aortic disease in Marfan syndrome via Akt activation
EMBO molecular medicine, Vol. 16, Núm. 1, pp. 132-157
2023
-
Metabolic Modulators in Cardiovascular Complications of Systemic Lupus Erythematosus
Biomedicines, Vol. 11, Núm. 12
-
Mineralocorticoid receptor blockade improved gut microbiota dysbiosis by reducing gut sympathetic tone in spontaneously hypertensive rats
Biomedicine and Pharmacotherapy, Vol. 158
-
Probiotics and Prebiotics in Cardiovascular Diseases
Nutrients
-
Protective effect of microbiota-derived short chain fatty acids on vascular dysfunction in mice with systemic lupus erythematosus induced by toll like receptor 7 activation
Pharmacological Research, Vol. 198
-
Solanum aethiopicum L. from the Basilicata region as a source of specialized metabolites with promising anti-obesity effects: phytochemical characterization and in vivo investigation in high fat diet-fed mice
Frontiers in Pharmacology, Vol. 14
-
Targeting the gut microbiota with dietary fibers: a novel approach to prevent the development cardiovascular complications linked to systemic lupus erythematosus in a preclinical study
Gut Microbes, Vol. 15, Núm. 2
-
The Prebiotic Effects of an Extract with Antioxidant Properties from Morus alba L. Contribute to Ameliorate High-Fat Diet-Induced Obesity in Mice
Antioxidants, Vol. 12, Núm. 4
2022
-
The Antioxidant Activity of Thymus serpyllum Extract Protects against the Inflammatory State and Modulates Gut Dysbiosis in Diet-Induced Obesity in Mice
Antioxidants, Vol. 11, Núm. 6
-
The melatonergic agonist agomelatine ameliorates high fat diet-induced obesity in mice through the modulation of the gut microbiome
Biomedicine and Pharmacotherapy, Vol. 153
2021
2020
-
Gut DYSBIOSIS and altered barrier function precedes the appearance of metabolic syndrome in a rat model of nutrient-induced catch-up growth
Journal of Nutritional Biochemistry, Vol. 81